Several blood tests have been shown to accurately diagnose Alzheimer’s disease — as previously ... Determining the clinical stage of dementia can help ensure that the patient receives the ...

Analyzing blood levels of MTBR-tau243 from a group of people with cognitive decline, the researchers were able to distinguish between people with early- or later-stage Alzheimer's disease and ...

By analyzing blood levels of MTBR-tau243 in a group of people with cognitive decline, the research team were able to distinguish between people with early- or later-stage Alzheimer’s disease and ...

March 27, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company ... at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD ...

March 25, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) ("NKGen” or the "Company”), a clinical-stage ... 5, 2025. AD/PD™ 2025 is a premier event bringing together top international experts ...

Shares of Cassava Sciences SAVA plunged 32.1% on Tuesday after the company announced that its lead pipeline candidate, simufilam, failed to meet the prespecified co-primary endpoints in the second ...

By analyzing blood levels of MTBR-tau243 in a group of people with cognitive decline, the research team were able to distinguish between people with early- or later-stage Alzheimer’s disease and ...